Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  CompuGroup Medical Societas Europaea    COP   DE0005437305

COMPUGROUP MEDICAL SOCIETAS EUROPAEA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

CompuGroup Medical SE: CompuGroup acquires parts of Cerner's IT Healthcare business in Germany and Spain and prepares the Change of Legal Form into a Partnership Limited by Shares (Kommanditgesellschaft auf Aktien, KGaA)

share with twitter share with LinkedIn share with facebook
02/05/2020 | 03:10am EDT

DGAP-Ad-hoc: CompuGroup Medical SE / Key word(s): Takeover/AGM/EGM
CompuGroup Medical SE: CompuGroup acquires parts of Cerner's IT Healthcare business in Germany and Spain and prepares the Change of Legal Form into a Partnership Limited by Shares (Kommanditgesellschaft auf Aktien, KGaA)

05-Feb-2020 / 08:08 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Today, CompuGroup Medical SE and Cerner Corporation have entered into a purchase agreement regarding the acquisition of parts of Cerner's IT Healthcare portfolio in Germany and Spain. The Supervisory Board of CompuGroup has already approved the transaction today.

The key products of the acquired portfolio are "medico" and "Soarian Integrated Care", leading hospital information systems (HIS) in Germany, "Selene", a leading HIS in Spain, and "Soarian Health Archive", a document archiving solution for healthcare providers.

The purchase price amounts to EUR 225 million and is subject to a price adjustment mechanism upon the closing day. For 2019, the revenues of the acquired business were approximately EUR 74 million and had an EBITDA of approximately EUR 13 million. The customer base of the acquired business consists of 251 hospitals in Germany and of 65 hospitals in Spain.

Closing of the transaction is expected for the 3rd quarter of 2020 and is subject to merger control clearance and other closing conditions.

In addition, the Management Board and the Supervisory Board of CompuGroup Medical SE (CGM) have resolved today to propose to the shareholders' meeting of CGM on May 13, 2020 a change of the legal form of the company into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA). The general partner (persönlich haftender Gesellschafter/Komplementär) of the KGaA shall be a monistically structured European Company (SE), which is held directly or indirectly at 100% by the founder of CGM Frank Gotthardt as well as further members of the Gotthardt family and Dr. Reinhard Koop (collectively the majority shareholders of CGM). The change of legal form shall enable the company to obtain the greatest possible flexibility with a view to the financing of future growth and to maintain at the same time with the founding family Gotthardt an anchor shareholder which keeps up the entrepreneurial approach and the founding spirit.

The change of legal form does not change the share that investors own in CompuGroup Medical. They will hold the same number of no-par-value bearer shares in the KGaA as they do in CGM prior to the change of legal form. The aggregate number of no-par-value shares issued remains unchanged.

The Management Board will prepare a conversion report for the resolution proposal, which will be made available to the shareholders together with the invitation. The majority shareholders of CGM, the Gotthardt family together with Dr. Koop, have informed CGM that they support the change of legal form.



Contact:
Claudia Thomé
Head of Investor Relations
CompuGroup Medical SE
email: claudia.thome@cgm.com
phone +49 261 8000 7030
phone +49 261 8000 6200

05-Feb-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 6200
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE0005437305
WKN: 543730
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 968249

 
End of Announcement DGAP News Service

968249  05-Feb-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=968249&application_name=news&site_id=zonebourse
© EQS 2020

share with twitter share with LinkedIn share with facebook
All news about COMPUGROUP MEDICAL SOCIETAS EUROPAEA
10/12COMPUGROUP MEDICAL : Berenberg reiterates its Buy rating
MD
10/09COMPUGROUP MEDICAL : Gets a Buy rating from Deutsche Bank
MD
10/08COMPUGROUP MEDICAL SE & CO. KGAA : Release according to Article 40, Section 1 of..
EQ
10/08COMPUGROUP MEDICAL : and NOWEDA intend to comprehensively digitize the patient j..
EQ
10/01COMPUGROUP MEDICAL SE & CO. KGAA : Release according to Article 40, Section 1 of..
EQ
09/25COMPUGROUP MEDICAL SE & CO. KGAA : Release according to Article 40, Section 1 of..
EQ
09/25COMPUGROUP MEDICAL SE & CO. KGAA : Notification and public disclosure of transac..
EQ
09/24COMPUGROUP MEDICAL SE & CO. KGAA : Release according to Article 40, Section 1 of..
EQ
09/24COMPUGROUP MEDICAL : Berenberg reiterates its Buy rating
MD
09/23COMPUGROUP MEDICAL SE & CO. KGAA : Release according to Article 40, Section 1 of..
EQ
More news
Financials
Sales 2020 832 M 983 M 983 M
Net income 2020 90,7 M 107 M 107 M
Net Debt 2020 320 M 379 M 379 M
P/E ratio 2020 42,8x
Yield 2020 0,68%
Capitalization 3 955 M 4 681 M 4 672 M
EV / Sales 2020 5,14x
EV / Sales 2021 4,58x
Nbr of Employees 5 444
Free-Float 49,9%
Chart COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Duration : Period :
CompuGroup Medical Societas Europaea Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 80,67 €
Last Close Price 73,60 €
Spread / Highest target 22,3%
Spread / Average Target 9,60%
Spread / Lowest Target -8,97%
EPS Revisions
Managers
NameTitle
Frank Gotthardt Chairman-Management Board & CEO
Philipp von Ilberg Chairman-Supervisory Board
Michael Rauch Chief Financial Officer
Hannes Reichl Director-Clinical & Social Care
Daniel Gotthardt Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
COMPUGROUP MEDICAL SOCIETAS EUROPAEA15.45%4 681
ORACLE CORPORATION13.06%180 352
SAP SE3.81%176 058
SERVICENOW INC.82.07%98 588
INTUIT INC.27.68%87 554
DOCUSIGN, INC.196.61%40 703